• Aztreonam Workflows for Gram-Negative Research

  2026-09-02

  Aztreonam combines selective activity against Gram-negative aerobic bacteria with practical utility in susceptibility, resistance-transfer, and mammalian safety workflows. This guide translates product characteristics and a Guangdong hospital transmission study into executable assay design, controls, and troubleshooting strategies.

• Gamithromycin: From Ribosome to PK/PD Precision

  2026-09-01

  Gamithromycin, also known as ML-1709460, offers a valuable translational model for connecting 50S ribosomal inhibition with matrix-aware pharmacodynamics, lung exposure, and pathogen-specific PK/PD targets. This article outlines how researchers can design more clinically meaningful veterinary respiratory infection studies.

• Heparin Affinity for Cancer Stemness Research

  2026-09-01

  A translational framework for using heparin affinity purification to improve the reproducibility, mechanistic resolution, and assay readiness of CCR7–Notch1 stemness studies.

• Faropenem sodium Research Workflows

  2026-08-31

  Build more informative antimicrobial assays with Faropenem sodium, a penem antibiotic suited to cell-wall, anaerobe, resistance, and transporter studies. This workflow-focused guide connects MIC testing with renal epithelial transport experiments and practical troubleshooting for reproducible results.

• Sisomicin: Practical Antibacterial Testing Workflows

  2026-08-30

  Sisomicin is a broad-spectrum aminoglycoside antibiotic suited to standardized MIC assays, pathogen-panel screening, and resistance-aware infection research. This guide translates historical clinical-isolate data into practical workflows for Gram-negative and Gram-positive models, with protocol parameters and troubleshooting guidance.

• Brassinolide: Mechanism, Evidence, and Research Use

  2026-08-29

  Brassinolide, also called 24-Epibrassinolide, is a steroidal plant hormone used to study growth regulation and selected mammalian cell responses. Available evidence supports plant bioassay activity, PC-3 apoptosis-related effects, and glucose lowering in an alloxan-induced diabetic rat model, but these findings do not establish a human therapeutic indication.

• Rifampin as a Translational Tool for Bacterial Control

  2026-08-29

  Rifampin is more than a bactericidal reagent: it is a mechanistically defined perturbation for connecting bacterial transcription, resistance, and translational assay design. This thought-leadership guide explains how to use its DNA-dependent RNA polymerase activity strategically across resistance mechanism research, transcriptional regulation studies, and synthetic biology.

• Levofloxacin: DNA Gyrase and Bone Research

  2026-08-28

  Levofloxacin is a synthetic fluoroquinolone antibiotic and DNA gyrase inhibitor used to study bacterial DNA replication and selected bone or cartilage endpoints. Product-reported solubility, osteoblast, calcium-deposition, and chondrocyte findings define practical research boundaries rather than universal clinical or cellular dose responses.

• U-73122: From PLC Mechanism to Translational Strategy

  2026-08-28

  U-73122 offers a practical way to interrogate phospholipase C activity across calcium flux, chemotaxis, inflammation, and cancer-cell invasion. This thought-leadership analysis connects mechanistic biology with experimental design, evidence evaluation, and translational decision-making.

• Exogenous NADH Boosts Antibiotics Against E. tarda

  2026-08-27

  A 2024 Virulence study shows that exogenous NADH can enhance neomycin bactericidal activity against Edwardsiella tarda by reprogramming purine and energy metabolism and increasing ATP levels. The work presents metabolic stimulation as an antibiotic-adjuvant strategy, while also indicating activity across additional antibiotic classes and clinically relevant bacterial species.

• Halazone: From Water Disinfection to Ion-Channel Insight

  2026-08-27

  Halazone is more than a water disinfection agent: its hypochlorous acid chemistry and unusual effects on sodium-current inactivation make it a valuable translational research probe. This article connects antimicrobial performance, membrane redox biology, neurophysiology, and practical assay design while separating established evidence from exploratory hypotheses.

• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-26

  The reference preprint shows that selected p38α inhibitors can do more than occupy the kinase active site: they can also expose the activation-loop phosphothreonine to the phosphatase WIP1. By combining biochemical dephosphorylation assays with X-ray structures, the study proposes conformational control of phosphatase access as a strategy for improving kinase-inhibitor specificity and durability.

• Levofloxacin Assays: Workflows and Troubleshooting

  2026-08-26

  Levofloxacin supports more than routine antibacterial testing: it can connect bacterial DNA replication studies with quantitative osteoblast and cartilage-metabolism assays. This guide translates resistance epidemiology into practical workflow choices, controls, and troubleshooting strategies.

• Coelenterazine Workflows for ROS Reporter Assays

  2026-08-25

  Coelenterazine links luciferase reporter output with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide adapts it for AVP reporter studies, BRET, oxidative stress measurement, high-throughput screening, and cancer-associated reactive oxygen species imaging while emphasizing solvent control and orthogonal validation.

• T-5224: C-Fos/AP-1 Inhibitor Evidence

  2026-08-25

  T-5224 is a selective C-Fos/AP-1 inhibitor that blocks c-Fos/c-Jun DNA binding and suppresses inflammatory and osteoclastogenic readouts in preclinical models. Product information reports activity against MMPs, IL-6, IL-1β, TNF-α, and NFAT, with oral efficacy in the collagen-induced arthritis (CIA) model.

452 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page